Compare Genworth Financial Inc Common Stock (GNW) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genworth Financial Inc Common Stock vs Nutrien Ltd — how do they compare? Genworth Financial Inc Common Stock trades at $8.82 (market cap $3.33B), while Nutrien Ltd trades at $69.87 (market cap $33.39B). The key difference: Nutrien Ltd is far larger — about 10× Genworth Financial Inc Common Stock's market cap, and Nutrien Ltd pays a 3.15% dividend while Genworth Financial Inc Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Genworth Financial Inc Common Stock for 0 Days and Nutrien Ltd for 60 Days on average.
| GNW | NTR | |
|---|---|---|
Market Cap | $3.33B | $33.39B |
Volume | 3,324,561 | 2,147,139 |
Sector | Financials | Basic Materials |
52-Week High | $10.60 | $83.94 |
52-Week Low | $7.94 | $53.64 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $2.85B | $45.20B |
Dividend Yield | — | 3.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Genworth Financial (GNW) trades at $8.89, down 1.77% today, with neutral technical signals and mixed fundamental performance. The company maintains stable revenue around $7.1-7.2B but faces margin pressure, with net income declining from $223M to $212M year-over-year. Recent Q2 2026 earnings beat expectations at $0.29 EPS, while the company expanded its share repurchase program by $500M in September 2026.
GNW presents value characteristics with low P/B (0.38) and P/S (0.49) ratios, but weak profitability metrics (ROE 2.42%) and analyst caution (70.59% hold rating) suggest limited near-term catalysts. Key risks include legacy insurance liabilities and competitive pressures, while the upcoming Q3 earnings on November 4 could provide directional clarity.
Nutrien (NTR) trades at $69.68, up 2.47% with mixed technical signals showing bearish momentum but oversold conditions. The company reported Q2 2026 earnings miss ($2.61 vs $2.70 expected) but maintains stable revenue growth projections. Strong institutional interest continues with BlackRock acquiring a $220 million position in Q2 2026, while analyst consensus remains positive with a $77.29 price target representing 11% upside potential.
The fertilizer producer faces near-term headwinds from potential Belarus potash imports but benefits from structural North American gas advantages. While technical indicators suggest caution, fundamental valuation metrics (P/E 14.11, P/S 1.19) appear reasonable given the company's market leadership position and improving profitability trends from 2024 lows.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Genworth Financial Inc Common Stock
Genworth Financial, Inc. is a holding company that provides products and services related to aging and long-term care planning, and is the parent company of publicly traded mortgage insurer Enact Holdings, Inc.
Read more on GNW →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
